<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1610222737
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DESIRETT 75 mcg Film-Coated Tablets
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DESOGESTREL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.075
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        13.05
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="LABORATORIOS LEON FARMA, S.A." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            LABORATORIOS LEON FARMA, S.A.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            EXELTIS GERMANY GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G03AC09
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Desirett is used to prevent pregnancy.<br />Desirett contains a small amount of one type of female sex hormone, the progestogen<br />desogestrel. For this reason Desirett is called a progestogen-only-pill (POP), or a mini-pill.<br />Contrary to the combined pill, the POP or mini-pill does not contain an oestrogen<br />hormone next to the progestogen.<br />Most POPs or minipills work primarily by preventing the sperm cells from entering the<br />womb but do not always prevent the egg cell from ripening, which is the primary action of<br />combined pills. Desirett is distinct from other mini-pills in having a dose that in most cases<br />is high enough to prevent the egg cell from ripening. As a result, Desirett provides high<br />contraceptive efficacy. In contrast to the combined pill, Desirett can be used by women<br />who do not tolerate oestrogens and by women who are breastfeeding.<br />A disadvantage is that vaginal bleeding may occur at irregular intervals during the use of<br />Desirett. You also may not have any bleeding at all.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Desirett, like other hormonal contraceptives, does not protect against HIV infection<br />(AIDS) or any other sexually transmitted disease.<br />Do not take Desirett<br />&middot; If you are allergic to any of the ingredients of Desirett.<br />&middot; If you have a thrombosis. Thrombosis is the formation of a blood clot in a blood vessel<br />(e.g. of the legs (deep venous thrombosis) or the lungs (pulmonary embolism)).<br />&middot; If you have or have had jaundice (yellowing of the skin) or severe liver disease and your<br />liver function is still not normal.<br />&middot; If you have or are suspected to have a cancer that is sensitive to progestogens, such as<br />certain types of breast cancer.<br />&middot; If you have any unexplained vaginal bleeding.<br />&middot; If you are allergic to peanut or soya.<br />Tell you doctor before you start to use Desirett if any of these conditions apply to you.<br />Your doctor may advise you to use a non-hormonal method of birth control.<br />Consult your doctor immediately if any of these conditions appear for the first time while<br />using Desirett.<br />Take special care with Desirett<br />Tell your doctor before you start to use Desirett, if<br />&middot; you have ever had cancer of the breast.<br />&middot; you have liver cancer, since a possible effect of Desirett cannot be excluded.<br />&middot; you have ever had a thrombosis.<br />&middot; you have diabetes.<br />&middot; you suffer from epilepsy (see section &lsquo;Taking other medicines&rsquo;).<br />&middot; you suffer from tuberculosis (see section &lsquo;Taking other medicines&rsquo;).<br />&middot; you have high blood pressure.<br />&middot; you have or have had chloasma (yellowish-brown pigmentation patches on the skin,<br />particularly of the face); if so avoid too much exposure to the sun or ultraviolet radiation.<br />When Desirett is used in the presence of any of these conditions, you may need to be<br />kept under close observation. Your doctor can explain what to do.<br />Desirett and breast cancer<br />Regularly check your breasts and contact your doctor as soon as possible if you feel any<br />lump in your breasts. Breast cancer has been found slightly more often in women who<br />take the Pill than in women of the same age who do not take the Pill. If women stop<br />taking the Pill, the risk gradually decreases, so that 10 years after stopping the risk is the<br />same as for women who have never taken the Pill. Breast cancer is rare under 40 years<br />of age but the risk increases as the woman gets older. Therefore, the extra number of<br />breast cancers diagnosed is higher if the age until which the woman continues to take the<br />Pill is higher. How long she takes the Pill is less important.<br />In every 10 000 women who take the Pill for up to 5 years but stop taking it by the age of<br />20, there would be less than 1 extra case of breast cancer found up to 10 years after<br />stopping, in addition to the 4 cases normally diagnosed in this age group. Likewise, in 10<br />000 women who take the Pill for up to 5 years but stop taking it by the age of 30, there<br />would be 5 extra cases in addition to the 44 cases normally diagnosed. In 10 000 women<br />who take the Pill for up to 5 years but stop taking it by the age of 40, there would be 20<br />extra cases in addition to the 160 cases normally diagnosed.<br />The risk of breast cancer in users progestogen-only pills like Desirett is believed to be<br />similar to that in women who use the Pill, but the evidence is less conclusive.<br />Breast cancers found in women who take the Pill, seem less likely to have spread than<br />breast cancers found in women who do not take the Pill. It is not known whether the<br />difference in breast cancer risk is caused by the Pill. It may be that the women were<br />examined more often, so that the breast cancer is noticed earlier.<br />Desirett and thrombosis<br />See your doctor immediately, if you notice possible signs of a thrombosis (see also<br />&#39;Regular Check-ups&#39;) Thrombosis is the formation of a blood clot which may block a blood<br />vessel. A thrombosis sometimes occurs in the deep veins of the legs (deep venous<br />thrombosis). If this clot breaks away from the veins where it is formed, it may reach and<br />block the arteries of the lungs, causing a so-called &ldquo;pulmonary embolism&rdquo;. As a result,<br />fatal situations may occur. Deep venous thrombosis is a rare occurrence. It can develop<br />whether or not you are taking the Pill. It can also happen if you become pregnant. The<br />risk is higher in Pill-users than in non-users. The risk with progestogen-only pills, like<br />Desirett, is believed to be lower than in users of Pills that also contain oestrogens<br />(combined Pills).<br />Taking other medicines<br />Please tell your doctor or pharmacist if you are taking or have recently taken any other<br />medicines or herbal products, including medicines obtained without a prescription. Some<br />medicines may stop Desirett from working properly.<br />These include medicines used for the treatment of epilepsy (e.g. primidone, phenytoin,<br />carbamazepine, oxcarbazepine, felbamate and Phenobarbital) or tuberculosis (e.g.<br />rifampicin), HIV infections (e.g. ritonavir) or other infectious diseases (e.g. griseofulvin),<br />stomach upset (medical charcoal), depressive moods (the herbal remedy St John&#39;s wort).<br />Your doctor can tell you if you need to take additional contraceptive precautions and if so,<br />for how long.<br />Desirett may also interfere with how certain medicines work, causing either an increase in<br />effect (e.g. medicines containing cyclosporine) or a decrease in effect.<br />Pregnancy and breast-feeding<br />Pregnancy<br />Do not use Desirett if you are pregnant, or think you may be pregnant.<br />Breast-Like all medicines, Desirett can cause side effects, although not everybody gets them.<br />Serious undesirable affects associated with the use of Desirett are described the<br />paragraphs &quot;Breast Cancer&quot; and &quot;Thrombosis&quot; in section 2 &ldquo;Before you take Desirett&rdquo;<br />Please read this section for additional information and consult your doctor at once where<br />appropriate.<br />Vaginal bleeding may occur at irregular intervals during the use of Desirett. This may be<br />just slight staining which may not even require a pad, or heavier bleeding, which looks<br />rather like a scanty period and requires sanitary protection. You may also not have any<br />bleeding at all. The irregular bleedings are not a sign that the contraceptive protection of<br />Desirett is decreased. In general, you need not take any action; just continue to take<br />Desirett. If, however, bleeding is heavy or prolonged consult your doctor.<br />&middot; Common side effects (affects 1 to 10 users in 100) are: mood altered, depressed mood,<br />decreased sexual drive (libido), headache, nausea, acne, breast pain, irregular or no<br />menstruation, increased body weight.<br />&middot; Uncommon side effects (affects 1 to 10 users in 1,000) are: infection of the vagina,<br />difficulties in wearing contact lenses, vomiting, hair loss, painful menstruation, ovarian<br />cyst, tiredness.<br />&middot; Rare side effects (affects 1 to 10 users in 10,000) are: rash, hives, painful blue-red skin<br />lumps (erythema nodosum). These are skin conditions.<br />Apart from these side effects, breast secretion may occur.<br />If any of the side effects gets serious, or if you notice any side effects not listed in this<br />leaflet, please tell your doctor or pharmacist.<br />You should see your doctor immediately if you experience symptoms of angioedema,<br />such as (i) swollen face, tongue or pharynx; (ii) difficulty to swallow; or (iii) hives and<br />difficulties to breathe.<br />Desirett may be used while you are breast-feeding. Desirett does not influence the<br />production or the quality of breast milk. However, a small amount of the active substance<br />of Desirett passes over into the milk.<br />The health of children breast-fed for 7 months whose mothers were using Desirett has<br />been studied up to 2.5 years of age. No effects on the growth and development of the<br />children were observed.<br />If you are breast-feeding and want to use Desirett, please contact your doctor.<br />Driving and using machines<br />There are no indications of any effect of the use of Desirett on alertness and concentration.<br />Important information about some of the ingredients of Desirett<br />Desirett contains lactose (milk sugar) and soy bean oil.<br />If you have been told by your doctor that you have an intolerance to some sugars, contact<br />your doctor before taking this medicinal product.<br />If you are allergic to peanut or soya, do not use this medicinal product.<br />Use in adolescents<br />No clinical data on efficacy and safety are available in adolescents below 18 years.<br />Regular check-ups<br />While you are using Desirett you should see your doctor regularly at least twice a year.<br />Contact your doctor as soon as possible if:<br />&middot; you have severe pain or swelling in either of your legs, unexplained pains in the chest,<br />breathlessness, an unusual cough, especially when you cough up blood (possibly<br />indicating a thrombosis).<br />&middot; you have a sudden, severe stomach ache or look jaundiced (possibly indicating liver<br />problems);<br />&middot; you feel a lump in your breast (possibly indicating breast cancer);<br />&middot; you have a sudden or severe pain in the lower abdomen or stomach area (possibly<br />indicating an ectopic pregnancy, this is a pregnancy outside the womb);<br />&middot; you are to be immobilised or are to have surgery (consult your doctor at least four<br />weeks in advance);<br />&middot; you have unusual, heavy vaginal bleeding;<br />&middot; you suspect that you are pregnant.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>When and how you should take Desirett<br />The Desirett pack contains 28 tablets. The days of the week are printed in the blister and<br />also arrows are printed indicating the order to take the pills. Each day correspond with<br />one tablet. Every time you start a new pack of Desirett, take a tablet from the top row.<br />Don&rsquo;t start with just any tablet. For example if you start on a Wednesday, you must take<br />the tablet from the top row marked with &lsquo;WED&rsquo; (Wednesday). Continue to take one tablet<br />a day until the pack is empty, always following the direction indicated by the arrows. By<br />looking at the pill pack you can easily check if you have already taken a tablet on a<br />particular day. Take your tablet each day at about the same time.<br />Swallow the tablet whole, with water. You may have some bleeding during the use of<br />Desirett, but you must continue to take your tablets as normal. When a pack is empty, you<br />must start with a new pack of Desirett on the next day &ndash; thus without interruption and<br />without waiting for a bleed.<br />When to start with the first strip Desirett<br />When no hormonal contraceptive has been used in the past month<br />Wait for your period to begin. On the first day of your period take the first Desirett tablet.<br />You need not take extra contraceptive precautions.<br />You may also start on days 2-5 of your cycle, but in that case make sure you also use an<br />additional contraceptive method (barrier method) for the first 7 days of tablet-taking.<br />When you change from a combined pill, vaginal ring, or transdermal patch<br />You can start taking Desirett on the day after you take the last tablet from the present Pill<br />pack, or on the last day of removal of your vaginal ring or patch (this means no tablet-,<br />ring- or patch-free break). If your present Pill pack also contains inactive tablets you can<br />start Desirett on the day after taking the last active tablet (if you are not sure which this is,<br />ask your doctor or pharmacist). If you follow these instructions, you need not take extra<br />contraceptive precautions.</p><p>You can also start at the latest the day following the tablet-, ring-, patch-free break, or<br />placebo tablet interval, of your present contraceptive. If you follow these instructions,<br />make sure you use an additional contraceptive method (barrier method) for the first 7<br />days of tablet-taking.<br />When changing from another progestogen-only (mini-pill)<br />You may stop taking it any day and start taking Desirett right away. You need not take<br />extra contraceptive precautions.<br />When changing from an injectable or implant or a progestogen-releasing intrauterine<br />device (IUD)<br />Start using Desirett when your next injection is due or on the day that your implant or your<br />IUD is removed. You need not take extra contraceptive precautions.<br />After having a baby<br />You can start Desirett between 21 and 28 days after the birth of your baby. If you start<br />later, make sure you use during the first cycle an additional contraceptive method (barrier<br />method) for the first 7 days of tablet-taking.<br />However, if intercourse has already occurred, pregnancy should be excluded before<br />starting Desirett use. Additional information for breast-feeding women can be found in<br />&#39;Pregnancy and Breast-feeding&#39; in section 2. Your doctor can also advise you.<br />After a miscarriage or a premature termination of pregnancy<br />Your doctor will advise you.<br />If you forget to take Desirett<br />If you are less than 12 hours late in taking a tablet, the reliability of Desirett is<br />maintained. Take the missed tablet as soon as you remember and take the next tablets at<br />the usual times.<br />If you are more than 12 hours late in taking any tablet, the reliability of Desirett may be<br />reduced. The more consecutive tablets you have missed, the higher the risk that the<br />contraceptive efficacy is decreased. Take the last missed tablet as soon as you<br />remember and take the next tablets at the usual times. Use an additional contraceptive<br />method (barrier method) too for the next 7 days of tablet-taking. If you missed one or<br />more tablets in the first week of tablet-intake and had intercourse in the week before<br />missing the tablets, there is a possibility of becoming pregnant. Ask your doctor for<br />advice.<br />If you suffer from gastro-intestinal disturbances (e.g. vomiting, severe diarrhoea)<br />or use medical charcoal<br />Follow the advice for missed tablets in the section above. If you vomit or use medical<br />charcoal within 3 - 4 hours after taking your Desirett tablet or have severe diarrhoea, the<br />active ingredient may not have been completely absorbed.<br />If you take more Desirett than you should<br />There are no mentions of seriously damaging results of taking too many Desirett pills<br />simultaneously. Should you have taken a number of pills simultaneously, you may suffer<br />from nausea, vomiting or vaginal blood loss. If you find out that a child has taken multiple<br />pills, contact your doctor for advice.<br />If you stop taking Desirett<br />You can stop taking Desirett whenever you want. From the day you stop you are no<br />longer protected against pregnancy.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Desirett can cause side effects, although not everybody gets them.<br />Serious undesirable affects associated with the use of Desirett are described the<br />paragraphs &quot;Breast Cancer&quot; and &quot;Thrombosis&quot; in section 2 &ldquo;Before you take Desirett&rdquo;<br />Please read this section for additional information and consult your doctor at once where<br />appropriate.<br />Vaginal bleeding may occur at irregular intervals during the use of Desirett. This may be<br />just slight staining which may not even require a pad, or heavier bleeding, which looks<br />rather like a scanty period and requires sanitary protection. You may also not have any<br />bleeding at all. The irregular bleedings are not a sign that the contraceptive protection of<br />Desirett is decreased. In general, you need not take any action; just continue to take<br />Desirett. If, however, bleeding is heavy or prolonged consult your doctor.<br />&middot; Common side effects (affects 1 to 10 users in 100) are: mood altered, depressed mood,<br />decreased sexual drive (libido), headache, nausea, acne, breast pain, irregular or no<br />menstruation, increased body weight.<br />&middot; Uncommon side effects (affects 1 to 10 users in 1,000) are: infection of the vagina,<br />difficulties in wearing contact lenses, vomiting, hair loss, painful menstruation, ovarian<br />cyst, tiredness.<br />&middot; Rare side effects (affects 1 to 10 users in 10,000) are: rash, hives, painful blue-red skin<br />lumps (erythema nodosum). These are skin conditions.<br />Apart from these side effects, breast secretion may occur.<br />If any of the side effects gets serious, or if you notice any side effects not listed in this<br />leaflet, please tell your doctor or pharmacist.<br />You should see your doctor immediately if you experience symptoms of angioedema,<br />such as (i) swollen face, tongue or pharynx; (ii) difficulty to swallow; or (iii) hives and<br />difficulties to breathe.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the sight and reach of children.<br />Do not store above 30 C.<br />Do not use Desirett after the expiry date which is stated on the carton after &rdquo;Do not use<br />after:&rdquo; or &ldquo;EXP:&rdquo;. The Expiry date refers to the last day of that month.<br />Medicines should not be disposed of via wastewater or household waste. Ask your<br />pharmacist how to dispose of medicines no longer required. These measures will help to<br />protect the environment.<br />The active substance etonogestrel shows an environmental risk to fish.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is: desogestrel (75 microgram)<br />The other ingredients are: lactose monohydrate, maize starch, povidone K30, d-&alpha;-tocopherol,<br />soybean oil, silica, colloidal anhydrous, silica, colloidal hydrated, stearic acid,<br />hypromellose, polyethylene glycol, titanium dioxide (E 171) (see also &quot;Important<br />information about some of the ingredients of Desirett&quot; in section 2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                One blister pack of Desirett contains 28 white round film-coated tablets. Each carton
contains 1 blister.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder and Manufacturer<br />Marketing Authorisation Holder<br />Exeltis Germany GmbH<br />Adalperostr. 84<br />85737 Ismaning<br />Germany<br />Manufacturer<br />Laboratorios Le&oacute;n Farma, S.A.<br />C/ La Vallina s/n, Pol. Ind. Navatejera.<br />24008 - Navatejera, Le&oacute;n.<br />Spain</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                September 2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>&nbsp;يستعمل دزيريت لمنع الحمل.<br />يحتوي دزيريت على كمية صغيرة من نوع واحد من هرمونات الجنس الأنثوية، البروجسترون ديسوجيستريل.<br />&nbsp;ولهذا السبب يُدعى دزيريت حبة-أحادية-البروجيستوجين (بي أو بي)، أو الحبة الصغيرة.<br />على عكس الأقراص المركبة، لا تحتوي حبة-أحادية-البروجيستوجين (بي أو بي) أو الحبة الصغيرة هرمون إيستروجين<br />بجانب البروجسترون.<br />تعمل الحبات-أحادية-البروجسترون أو الحبات الصغيرة أولياً بمنع االحيوانات المنوية من اختراق الرحم ولكنها لا تمنع<br />دائماً من نُضج البويضات، وهو الذي يعتبر المفعول الأساسي للحبوب المركبة. يختلف دزيريت&nbsp;عن الحبات&nbsp;<br />الصغيرة الأخرى في أنه يحتوي على جرعة عالية تكفي في معظم الحالات لمنع البويضات من النضج. وبالنتيجة،<br />يوفر دزيريت فعالية عالية لمنع الحمل. وبالمقارنة مع الأقراص المركبة، يمكن استعمال دزيريت&nbsp;&nbsp;من<br />قبل النساء اللاتي لا يتحملن الإستروجينات ومن قبل الأمهات اللاتي يرضعن.<br />النزف المهبلي أمر سلبي قد يحدث بفترات غير منتظمة أثناء استعمال دزيريت&nbsp;وقد لا تتعرضين لأي نزف<br />على الإطلاق.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال في موانع الحمل الهرمونية الأخرى، لا يقي دزيريت&nbsp;من عدوى فيروس نقص المناعة البشري<br />(الإيدز) أو أي مرض آخر ينتقل جنسياً.<br />&nbsp;لا تتناولي دزيريت<br />إن كنت تتحسسين من أي من مكونات دزيريت &middot;<br />إن كنت مصابة بتجلط. التجلط هو عبارة عن تشكل خثرة دموية في الوعاء الدموي (مثال الأوعية الدموية &middot;<br />للساقين (التخثر الوريدي العميق) أو الرئتين (الانصمام الرئوي)).<br />إن كنت مصابة أو أُ ِ صبت سابقاً بيرقان (اصفرار الجلد) أو مرض كبدي شديد والوظيفة الكبدية لديك مازالت غير &middot;<br />طبيعية.<br />إن كنت مصابة أو قد تكونين مصابة بسرطان حساس للإستروجينات، مثل أنواع محددة من سرطان الثدي. &middot;<br />إن كنت مصابة بأي نزف مهبلي غير معلوم السبب. &middot;<br />إن كنت تتحسسين من الفول السوداني أو الصويا. &middot;<br />إن كان أي من هذه الحالات ينطبق عليك. &nbsp; أخبري طبيبك قبل البدء باستعمال دزيريت<br />قد ينصحك طبيبك باستعمال طريقة غير هرمونية لمنع الحمل.<br />&nbsp;استشيري طبيبك فوراً إن ظهر أي من هذه الحالات لأول مرة أثناء استعمال دزيريت<br />&nbsp;محاذير خاصة عند استعمال دزيريت<br />إذا أخبري طبيبك قبل البدء باستعمال دزيريت<br />أُ ِ صبت في أي وقت مضى بسرطان الثدي. &middot;<br />كنت مصابة بسرطان الكبد، حيث إنه لا يمكن استثناء تأثير دزيريت&nbsp;المحتمل.&nbsp;<br />أُ ِ صبت في أي وقت مضى بتخثر. &middot;<br />كنت مصابة بداء السكري. &middot;<br />كنت تعانين من صرع (اقرئي فقرة &quot;تناول أدوية أخرى&quot;). &middot;<br />كنت تعانين من سل رئوي (اقرئي فقرة &quot;تناول أدوية أخرى&quot;). &middot;<br />كنت مصابة بارتفاع ضغط الدم. &middot;<br />كنت مصابة أو أُ ِ صبت سابقاً بكَلف (بقع صبغية لونها بني مصفر على الجلد، خصوصاً جلد الوجه)؛إن كان ذلك،&nbsp;<br />تجنبي التعرض للشمس أو الأشعة فوق البنفسجية.<br />&nbsp;إذا كان دزيريت يُستعمل بوجود أي من هذه الحالات، فقد تكون هناك حاجة لوضعك تحت الملاحظة عن قرب.<br />وسوف يوضح لك طبيبك ما عليك فعله.<br />&nbsp;دزيريت وسرطان الثدي<br />افحصي ثدييك بانتظام وتواصلي مع طبيبك فوراً إن كنت تشعرين بأي كتل في ثدييك. وجد ان سرطان الثدي غالبا<br />ما يظهر في النساء اللاتي يتناولن حبوب منع الحمل أكثر بقليل من غيرهن من النساء من نفس الفئة اللاتي لا<br />يتناولن الحبة.<br />إذا توقف النساء عن تناول الحبة، يقل الخطر تدريجياً، ولذلك فإن الخطر بعد وقف تناول الحبة بعشر سنوات هو نفسه<br />في حالة النساء اللاتي لم يتناولن الحبة. يعد سرطان الثدي نادراً في النساء الأصغر من ٤٠ سنة من العمر ولكن<br />الخطر يزداد عند تقدم المرأة بالسن. لذا نجد نسبة أكثر من الإصابات بسرطان الثدي المشخصة إذا كان عمر المرأة<br />المستمرة في تناول الحبة أكبر. ويعد طول مدة تناولها للحبة أقل أهمية.<br />في كل ١٠,٠٠٠ سيدة تناولن حبوب منع الحمل لمدة ٥ سنوات، لكنهن أوقفن الاستعمال في سن ٢٠ سنة، تمت<br />ملاحظة، بالإضافة إلى الأربع حالات المشخصة بشكل عادي لدى هذه الفئة العمرية، أقل من حالة إضافية من<br />الإصابة بسرطان الثدي، وذلك بعد ١٠ سنوات من وقف تناول الحبوب. وعلى غرار ذلك، من أصل ١٠,٠٠٠ سيدة تناولن<br />حبوب منع الحمل لمدة ٥ سنوات، لكنهن أوقفن الاستعمال في سن ٣٠ سنة، لوحظ، إضافة إلى ٤٤ حالة مشخصة<br />بشكل عادي لدى هذه الفئة العمرية، ٥ حالات إضافية من الإصابة بسرطان الثدي. ومن ١٠,٠٠٠ سيدة تناولن حبوب<br />منع الحمل لمدة ٥ سنوات، لكنهن أوقفن الاستعمال في سن ٤٠ سنة لوحظ، إضافة إلى ١٦٠ حالة مشخصة<br />بشكل عادي لدى هذه الفئة العمرية، ٢٠ حالة إضافية من الإصابة بسرطان الثدي.<br />نستخلص أن خطر الإصابة بسرطان الثدي بسبب تناول أقراص البروجسترون الخالصة يعادل خطر ا الإصابة بالمرض<br />بسبب الحبوب المركبة ولكن البرهان أقل جزماً.<br />يبدو أن سرطانات الثدي التي وجدت في النساء اللاتي يتناولن الحبة أقل احتمالاً للانتشار بالمقارنة مع سرطانات<br />الثدي التي وجدت في النساء اللاتي لا يتناولن الحبة. وليس معلوماً إن كان الاختلاف في خطر سرطان الثدي سببه<br />الحبة. ويحتمل أن تكون الفحوصات الدورية التي تقوم بها هؤلاء السيدات هي التي تساهم في اكتشاف السرطان<br />باكراً.<br />&nbsp;دزيريت والتخثر<br />قم بزيارة طبيبك فوراً، إذا لاحظت ظهور علامات محتملة للتخثر (اقرأ أيضاً &quot;الفحوصات المنتظمة&quot;). التخثر عبارة<br />عن تشكل خثرة دموية تسد الوعاء الدموي. يحدث التخثر أحياناً في الأوردة العميقة للساقين (التخثر الوريدي<br />العميق). وإذا انتقلت الخثرة هذه من الأوردة حيث تشكلت، قد تصل إلى شرايين الرئتين مسببة انسدادهما، وهو ما<br />يسمى &quot;الانصمام الرئوي&quot;. وبالنتيجة، قد تحدث حالات قاتلة. ويحدث التخثر الوريدي العميق نادراً. ومن الممكن أن<br />تحدث سواءاً تتناولين أو لا تتناولين الحبة. ومن الممكن أن تحدث أيضاً عندما تصبحين حاملاً. والخطر أكبر لدى<br />المستخدمات للحبة بالمقارنة مع غير المستخدمات.<br />واحتمال الإصابة يبقى اقل لدى النساء اللواتي يستعملن حبوب البروجسترون الخالصة (الحبات أحادية-<br />منه لدى اللواتي يستعملن الحبوب التي تحتوي أيضا على الأستروجين (الحبوب Desirett البروجسترون ) مثل دزيريت<br />المركبة).<br />تناول دزيريت مع أدوية أخرى<br />من فضلك أخبري طبيبك أو الصيدلي إن كنت تتناولين أو تناولت حديثاً أي أدوية أو منتجات عشبية أخرى، بما في<br />ذلك الأدوية التي حصلت عليها بدون وصفة طبية.&nbsp; تمنع بعض الأدوية دزيريت من أداء عمله كما يجب.<br />وتشمل الأدوية التي تستعمل لعلاج الصرع (مثل بريميدون، فينايتوين، كاربامازيبين، أوكزاكاربازيبين، فيلباميت<br />وفينوباربيتال) أو السل الرئوي (مثل ريفامبيسين)، عدوى فيروس نقص المناعة البشري (مثل ريتونافير) أو أمراض<br />عدوى أخرى (مثل غريسيوفلفين)، اضطراب المعدة (الفحم الطبي)، الاكتئاب (نبتة سانت جونز العشبية).<br />سوف يخبرك طبيبك إن كنت بحاجة لاتخاذ إجراءات منع حمل إضافية وسوف يخبرك عن مدتها إن كان عليك فعل<br />ذلك.<br />وقد يؤثر دزيريت أيضاً على طريقة عمل أدوية معينة، مسبباً إما زيادة في التأثير (مثل الأدوية المحتوية على<br />سايكلوسبورين) أو انخفاض في التأثير.<br />الحمل والإرضاع<br />الحمل<br />لا تستعملي دزيريتإن كنت حاملاً، أو تظنين أنك حاملاً.</p><p>الإرضاع<br />يمكن استعمال دزيريت&nbsp;أثناء الإرضاع. لا يؤثر دزيريت&nbsp;على إنتاج أو نوعية حليب الرضاعة. مع ذلك<br />كمية قليلة من المادة الفعالة لدزيريت ينفذ إلى الحليب.<br />دُرست صحة الأطفال الذين أُر ِ ضعوا لمدة ٧ أشهر من قبل أمهات كانوا يستعملن دزيريت إلى حد ٢٫٥ سنة&nbsp;<br />من العمر. ولم يُلاحظ تأثيرات على نمو وتطور الأطفال.</p><p><br />إن كنت مرضعة وتريدين استعمال دزيريت من فضلك تواصلي مع طبيبك.</p><p><br />القيادة واستعمال المكائن<br />لا يوجد ما يشير إلى وجود أي تأثير من استعمال دزيريت على الانتباه والتركيز.<br />&nbsp;معلومات مهمة عن بعض مكونات دزيريت<br />يحتوي دزيريت على لاكتوز (حليب السكر) وزيت فول الصويا.<br />إن كنت أُخبرت من قبل طبيبك أنك لا تتحملين بعض أنواع السكر، تواصلي مع طبيبك قبل تناول هذا المنتج الطبي.<br />إن كنت تتحسسين من الفول السوداني أو الصويا، لا تستعملين هذا المنتج الطبي.<br />الاستعمال لدى المراهقين<br />لا توجد معلومات سريرية عن الفعالية والسلامة في المراهقين الأصغر من ١٨ سنة.<br />فحوصات منتظمة<br />أثناء استعمال دزيريت يجب عليك القيام بزيارة الطبيب بانتظام مرتين في السنة على الأقل<br />تواصلي مع طبيبك فوراً إذا:<br />أصبت بألم أو تورم شديد في أحد الساقين، آلام صدرية غير معلومة السبب، ضيق النفس، سعال غير معتاد، &middot;<br />خصوصاً عندما يكون سعالك مصحوباً بدم (يشير إلى احتمال التخثر).<br />أصبت بوجع معدي مفاجئ، شديد أو تبدين مصابة بيرقان (يشير إلى احتمال مشاكل كبدية)؛ &middot;<br />كنت تشعرين بكتلة في ثديك (يشير إلى احتمال سرطان الثدي)؛ &middot;<br />شعرت بألم مفاجئ أو شديد في الأمعاء السفلى أو منطقة المعدة (يشير إلى الحمل خارج الرحم)؛ كنت سوف &middot;<br />تُثبتين أو سوف تخضعين لجراحة (استشيري طبيبك أربعة أسابيع على الأقل مسبقاً)؛<br />أصبت بنزف مهبلي شديد، غير معتاد؛ &middot;<br />كنت تشكين أنك حاملاً.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>متى وكيف يجب عليك تناول دزيريت<br />تحتوي عبوة دزيريت على ٢٨ قرص. أيام الأسبوع مطبوعة على الشريط وكذلك توجد أسهم مطبوعة<br />تشير إلى ترتيب تناول الحبات. كل يوم يطابق قرص واحد. كل مرة تبدئين فيها استعمال عبوة دزيريت<br />جديدة، خذي القرص من السهم العلوي. لا تبدئي بأخذ أي قرص عشوائياً. على سبيل المثال، إذا كنت سوف تبدئين&nbsp;يوم الأربعاء،<br />يجب عليك أخذ القرص من السهم العلوي المطبوع عليه (الأربعاء). استمري في تناول قرص&nbsp; &quot;WED&quot;<br />واحد في اليوم إلى أن تفرغ العبوة، بالاتباع الدائم للتعليمات التي تشير إليها الأسهم. يمكنك بالنظر إلى العبوة أن<br />تلاحظي بسهولة إن كنت تناولت القرص في ذلك اليوم المحدد. تناولي قرصك كل يوم في نفس الوقت تقريباً.</p><p><br />ابتلعي القرص بالكامل، مع الماء. قد تتعرضين لحدوث نزف أثناء استعمال دزيريت ولكن يجب عليك<br />الاستمرار في تناول أقراصك كالمعتاد. عندما تفرغ العبوة، يجب عليك البدء بعبوة جديدة من دزيريت في<br />اليوم التالي &ndash; دون انقطاع ودون انتظار نزول الدم.<br />&nbsp;متى تبدئين بأول شريط من دزيريت<br />في حالة عدم استعمال مانع حمل هرموني في الشهر السابق<br />انتظري حتى تبدأ دورتك الشهرية. تناولي أول قرص من دزيريت في أول يوم من دورتك الشهرية. وأنت ليس<br />بحاجة لاحتياطات منع حمل إضافية.<br />يمكنك أيضاً بالبدء في اليوم 2-5 من دورتك الشهرية، ولكن في هذه الحالة تأكدي من أنك تستعملين أيضاً طريقة -<br />إضافية لمنع الحمل (طريقة حائلة) لأول ٧ أيام من تناول الأقراص.</p><p>إذا سبق واستعملت حبوب منع الحمل المركبة أو اللولب، أو لصقة جلدية</p><p>يمكنك البدء بتناول دزيريت&nbsp;في اليوم التالي لتناولك آخر قرص من العبوة الحالية، أو في آخر يوم لإزالتك&nbsp;حلقة المهبل (اللولب) أو اللصقة (وهذا يعني أنه لا توجد فترة فاصلة بعد القرص، اللولب أو اللصقة). إذا كانت</p><p>عبوتك الحالية أيضاً تحتوي على أقراص غير فعالة، يمكنك البدء بدزيريت&nbsp;في اليوم التالي لتناول آخر قرص&nbsp;</p><p>فعال (إن كنت غير متأكدة، اسألي طبيبك أو الصيدلي). إذا اتبعت هذه التعليمات، فأنت ليس بحاجة لاحتياطات<br />منع حمل إضافية.</p><p>كما يمكنك البدء في آخر وقت اليوم التالي للفترة الفاصلة للقرص، الحلقة (اللولب)، اللصقة، أو فترة القرص<br />الوهمي. إذا اتبعتي هذه التعليمات، تأكدي من أنك تستعملين طريقة إضافية لمنع الحمل (طريقة حائلة) لأول ٧ أيام<br />من تناول الأقراص.</p><p>عندما تغيرين من بروجيستوجين-أحادي آخر (حبة-صغيرة)</p><p>تستطيعين وقف تناوله في أي يوم والبدء باستعمال دزيريت&nbsp;فوراً. وأنت لست بحاجة لاحتياطات منع حمل&nbsp;إضافية.</p><p>عندما تغيرين من الحقنة أو الغرز أو وسيلة داخل الرحم مطلقة للبروجيستوجين (آي يو دي)</p><p>ابدئي باستعمال دزيريت&nbsp;عندما يحين وقت الحقنة التالية أو في اليوم الذي أزيل فيه الغرز أو الوسيلة داخل</p><p>الرحم المطلقة للبروجيستوجين (آي يو دي). وأنت لست بحاجة لاحتياطات منع حمل إضافية.</p><p>بعد الولادة</p><p>يمكنك البدء ياستعمال دزيريت&nbsp;ما بين ٢١ و ٢٨ يوم بعد ولادة طفلك. إذا بدأت لاحقاً، احرصي على استعمال</p><p>طريقة منع حمل إضافية (طريقة حائلة) أثناء الدورة الأولى في أول ٧ أيام من تناول القرص</p><p>مع ذلك، إذا حصل الجِماع، يجب التأكد من عدم حدوث الحمل قبل البدء ياستعمال دزيريت&nbsp;يمكن الحصول</p><p>على مزيد من المعلومات بخصوص النساء المرضعات في &quot;الحمل والإرضاع&quot; في فقرة رقم ٢. وقد تحصلين على نصيحة<br />طبيبك أيضاً.</p><p>بعد الإجهاض أو انتهاء الحمل المبكر<br />سوف تحصلين على نصيحة طبيبك.</p><p>إذا نسيت تناول دزيريت</p><p>إذا تأخرت عن تناول القرص لأقل من ١٢ ساعة، الاعتمادية على دزيريت&nbsp;مأمونة. تناولي القرص الذي نسيتيه</p><p>فور تذكره وخذي الأقراص التالية في الوقت المعتاد.</p><p>إذا تأخرت عن تناول القرص لأكثر من ١٢ ساعة، الاعتمادية على دزيريت&nbsp;تقل. كلما زاد عدد مرات نسيانك</p><p>لتناول الأقراص، زاد خطر نقصان مفعول منع الحمل. تناولي آخر قرص نسيت تناوله فور تذكره وخذي الأقراص التالية<br />في الوقت المعتاد.<br />استعملي طريقة إضافية لمنع الحمل (طريقة حاجبة) لمدة ٧ أيام تالية لتناول القرص. إذا نسيت تناول قرص أو أكثر<br />في أول أسبوع من بدئك الاستعمال وحصل ِ جماع في الأسبوع قبل نسيان الأقراص، هناك احتمالية أن يحصل<br />الحمل. اطلبي النصيحة من طبيبك.</p><p>إن كنت تعانين من اضطرابات معدية-معوية (مثل تقيؤ، إسهال شديد) أو تستعملين فحم طبي<br />اتبع النصيحة فيما يتعلق بالأقراص التي نسيت تناولها في الفقرة العلوية. إذا تقيأت أو استعملت فحم طبي خلال</p><p>3-4ساعات بعد تناول قرص دزيريتأو تعرضت لإسهال شديد، فقد لا تكون المادة الفعالة قد امتصَّت بالكامل</p><p>إذا تناولت دزيريت أكثر مما يجب</p><p>لم تُذكر نتائج تلف خطيرة من تناول كمية كبيرة من حبات دزيريت&nbsp;في وقت واحد. إذا تناولت العديد من</p><p>الحبات في وقت واحد، قد تعانين من غثيان، تقيؤ أو فقدان دم مهبلي. إذا وجدت أن الطفل تناول حبات عديدة، تواصلي<br />مع طبيبك لنيل النصيحة.</p><p>إذا توقفت عن تناول دزيريت</p><p>يمكنك التوقف عن تناول دزيريت&nbsp;وقتما ترغبين. لم تعودين محمية من الحمل ابتداءاً من اليوم الذي توقفت&nbsp;فيه عن تناوله.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>كما هو الحال في كل الأدوية، يمكن أن يسبب دزيريت&nbsp;آثاراً جانبية على الرغم من أنها لا تحدث عند كل</p><p>شخص. ذُكرت آثار غير مرغوبة خطيرة مرتبطة باستعمال دزيريت&nbsp;في الفقرتين &quot;سرطان الثدي&quot; و</p><p>&quot;التخثر&quot; في فقرة رقم ٢ &quot;قبل تناول دزيريت&nbsp;من فضلك اقرئي هذه الفقرة لمزيد من المعلومات واستشيري طبيبك عند الحاجة.</p><p>قد يحدث نزف مهبلي على فترات غير منتظمة أثناء استعمال دزيريت&nbsp;وقد يكون هذا مجرد بقعة بسيطة&nbsp;</p><p>لا تحتاج لفوطة، أو نزف أشد، ما يبدو دورة خفيفة وتحتاج لوقاية صحية. وقد لا تتعرضين لأي نزف نهائياً. لا يعد النزف&nbsp;غير المنتظم علامة بأن مفعول دزيريت</p><p>المانع للحمل قد انخفض. عموماً، أنت ليس بحاجة لأخذ أي إجراء؛&nbsp;عليك الاستمرار في تناول دزيريت</p><p>إذا، مع ذلك، كان النزف شديداً أو مطولاً، استشيري طبيبك. .</p><p>آثار جانبية شائعة (تصيب من ١ إلى ١٠ مستخدمين من ضمن ١٠٠ ): تقلب المزاج، اكتئاب، نقص الغريزة الجنسية، &middot;<br />صداع، غثيان، حب الشباب، ألم في الثدي، دورة شهرية غير منتظمة أو لا تحدث، زيادة وزن الجسم.<br />آثار جانبية غير شائعة (تصيب من ١ إلى ١٠ مستخدمين من ضمن ١٠٠٠ ): عدوى المهبل، صعوبات في تثبيت &middot;<br />العدسات اللاصقة، تساقط الشعر، دورة شهرية مصحوبة بألم، تكيس المبايض، إجهاد.<br />آثار جانبية نادرة (تصيب من ١ إلى ١٠ مستخدمين من ضمن ١٠٠٠٠ ): طفح، شرى، كتل جلدية زرقاء-حمراء مؤلمة &middot;<br />(حمامى عقدية). وهذه حالات جلدية.<br />وإلى جانب هذه الآثار الجانبية، قد يحدث إفراز للحليب.<br />إذا تفاقم أي من الآثار الجانبية، أو لا حظت حدوث أي آثار جانبية غير مذكورة في هذا النشرة، من فضلك أخبر طبيبك<br />أو الصيدلي.<br />( يجب عليك القيام بزيارة طبيبك فوراً إذا تعرضت لأعراض الوذمة الوعائية، مثل ( ١) تورم الوجه، اللسان أو الحلق؛ ( ٢<br />صعوبة في البلع؛ أو ( ٣) شرى وصعوبة في التنفس.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول ونظر الأطفال.<br />لا تحفظه عند درجة حرارة أعلى من ٣٠ &deg;م.</p><p>لا تستعمل دزيريت&nbsp;بعد تاريخ الانتهاء المذكور على الغلاف الخارجي بعد &quot;لا تستعمله بعد:&quot; او&nbsp;EXP&quot;</p><p>يشير تاريخ الانتهاء إلى آخر يوم في الشهر.&nbsp;</p><p>يجب عدم التخلص من الأدوية عن طريق المياه العادمة أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من<br />الأدوية التي لم تعد بحاجة إليها. هذه الإجراءات سوف تساعد على حماية البيئة.<br />المادة الفعالة هي إتونوجيستريل تُظهر خطراً بيئياً على الأسماك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المكونات الأخرى هي: لاكتوز أحادي الهيدرات، نشا ذرة، بوفيدون كي ٣٠ ، دي-إيه-توكوفيرول، زيت فول الصويا، سيليكا<br />غروانية لامائية، سيليكا غروانية مائية، حمض الستياريك، هيبروميللوز، بولي إيثيلين جلايكول، تيتانيوم ثنائي<br />اقرأ أيضاً &quot;معلومات هامة عن بعض مكونات دزيريت .( في فقرة رقم ٢ )&quot;Desirett الأكسيد (إي ١٧١ )&nbsp;<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>يحتوي الشريط الواحد من دزيريت&nbsp;على ٢٨ قرص مغلف دائرية الشكل بيضاء اللون. كل كرتونة تحتوي على</p><p>1 شريط.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>مالك حق التسويق<br />إكزيلتيس جيرماني جي إم بي إتش<br />أدالبيروستر. ٨٤<br />٨٥٧٣٧ إسمانينج<br />ألمانيا<br />المصنع<br />لابوريتوريوس ليون فارما، إس. إيه.<br />سي/ لا فالينا إس/إن، بول. إند. نافاتيجيرا.<br />٢٤٠٠٨ &ndash; نافاتيجيرا، ليون.<br />اسبانيا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            بتاريخ مايو ٢٠١٥
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Desirett 75 microgram film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains 75 microgram of desogestrel
Excipients with known effects: Lactose monohydrate 55 mg, soybean oil (maximum 0.026 mg).
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet.
White, round.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Oral contraception</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Route of administration: oral use<br />Special populations<br />Renal impairment: no clinical studies have been performed in patients with renal impairment.<br />Hepatic impairment: no clinical studies have been performed in patients with hepatic insufficiency. Since the metabolism of steroid hormones might be impaired in patients with severe hepatic disease, the use of desirett in these women is not indicated as long as liver function values have not returned to normal</p><p>esogestrel 75 mcg<br />How to use Desirett<br />Tablets must be taken every day at about the same time so that the interval between two tablets always is 24 hours. The first tablet should be taken on the first day of menstrual bleeding. Thereafter one tablet each day is to be taken continuously, without taking any notice on possible bleeding. A new blister is started directly the day after the previous one.<br />How to start Desirett<br />No preceding hormonal contraceptive use [in the past month]<br />Tablet taking has to start on day 1 of the woman&rsquo;s natural cycle (day 1 is the first day of her menstrual bleeding).<br />Starting on days 2-5 is allowed, but during the first cycle a barrier method is recommended for the first 7 days of tablet-taking.<br />Following first-trimester abortion:<br />After first-trimester abortion it is recommended to start immediately. In that case there is no need to use an additional method of contraception.<br />Following delivery or second-trimester abortion:<br />Contraceptive treatment with Desirett after delivery can be initiated before the menstruations have returned. If more than 21 days have elapsed pregnancy ought to be ruled out and an additional method of contraception should be used for the first week.<br />However, if intercourse has already occurred, pregnancy should be excluded before the actual start of desirett use or the woman has to wait for her first menstrual period.<br />For additional information for breastfeeding women see Section 4.6.<br />How to start Desirett when changing from other contraceptive methods<br />Changing from another combined oral contraceptive (combined hormonal contraceptive (COC), vaginal ring or transdermal patch)<br />The woman should start with Desirett preferably on the day after the last active tablet (the last tablet containing the active substances) of her previous COC or on the day of removal of her vaginal ring or transdermal patch. In these cases, the use of an additional contraceptive is not necessary.<br />The woman may also start at the latest on the day following the usual tablet-free, patch-free, ring-free, or placebo tablet interval of her previous combined hormonal contraceptive, but during the first 7 days of tablet-taking an additional barrier method is recommended.<br />Changing from a progestogen-only method (minipill, injection, implant) or from a progestogen-releasing intrauterine system (IUS)<br />The woman may switch any day from the minipill (from an implant or the IUS on the day of its removal, from an injectable when the next injection would be due.<br />Management of missed tablets<br />Contraceptive protection may be reduced if more than 36 hours have elapsed between two tablets. If the user is less than 12 hours late in taking any tablet, the missed tablet should be taken as soon as it is remembered and the next tablet should be taken at the usual time. If she is more than 12 hours</p><p>late, she should use an additional method of contraception for the next 7 days. If tablets were missed in the first week and intercourse took place in the week before the tablets were missed, the possibility of a pregnancy should be considered.<br />Advice in case of gastrointestinal disturbances or use of medical charcoal<br />In case of severe gastrointestinal disturbance, absorption may not be complete and additional contraceptive measures should be taken. If vomiting occurs within 3-4 hours after tablet taking absorption may not be complete. In such an event the advice concerning missed tablets as given in section 4.2 is applicable<br />Treatment surveillance<br />Before prescription, a thorough case history should be taken and a thorough gynaecological examination is recommended to exclude pregnancy. Bleeding disturbances, such as oligomenorrhoea and amenorrhoea should be investigated before prescription. The interval between check-ups depends on the circumstances in each individual case. If the prescribed product may conceivably influence latent or manifest disease (see Section 4.4), the control examinations should be timed accordingly.<br />Despite the fact that Desirett is taken regularly, bleeding disturbances may occur. If the bleeding is very frequent and irregular, another contraceptive method should be considered. If the symptoms persist, an organic cause should be ruled out.<br />Management of amenorrhoea during treatment depends on whether or not the tablets have been taken in accordance with the instructions and may include a pregnancy test.<br />The treatment should be stopped if a pregnancy occurs.<br />Women should be advised that Desirett does not protect against HIV (AIDS) and other sexually transmitted diseases.<br />The safety and efficacy of desogestrel in adolescents below 18 years has not yet been established. No data are available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Active venous thromboembolic disorder.
 Presence or history of severe hepatic disease as long as liver function values have not returned to normal.
 Known or suspected sex-steroid sensitive malignancies.
 Undiagnosed vaginal bleeding.
 Hypersensitivity to the active substance or to any of the excipients.
 if you are allergic to peanut or soya.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>If any of the conditions/risk factors mentioned below is present the benefits of progestogen use should be weighed against the possible risks for each individual woman and discussed with the woman before she decides to start Desirett. In the event of aggravation, exacerbation, or first</p><p>appearance of any of these conditions, the woman should contact her physician. The physician should then decide on whether the use of Desirett should be discontinued.<br />The risk for breast cancer increases in general with increasing age. During the use of combined oral contraceptives (COCs) the risk for having breast cancer diagnosed is slightly increased. This increased risk disappears gradually within 10 years after discontinuation of COC use and is not related to the duration of use, but to the age of the woman when using the COC. The expected number of cases diagnosed per 10 000 women who use combined COCs (up to 10 years after stopping) relative to never users over the same period has been calculated for the respective age groups and is presented in the table below.</p><p><img alt="" width="817" height="231" src="data:image/png;base64,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" /></p><p>The risk in users of progestogen-only contraceptives (POC), such as Desirett, is possibly of similar magnitude as that associated with COCs. However, for POCs the evidence is less conclusive. Compared to the risk of getting breast cancer even in life, the increased risk associated with COCs is low. The cases of breast cancer diagnosed in COC users tend to be less advanced than in those who have not used COCs. The increased risk in COC users may be due to an earlier diagnosis, biological effects of the pill or a combination of both.<br />Since a biological effect of progestogens on liver cancer cannot be excluded an individual benefit/risk assessment should be made in women with liver cancer.<br />When acute or chronic disturbances of liver function occur, the woman should be referred to a specialist for examination and advice.<br />Epidemiological investigations have associated the use of COCs with an increased incidence of venous thromboembolism (VTE, deep venous thrombosis and pulmonary embolism). Although the clinical relevance of this finding for desogestrel used as a contraceptive in the absence of an oestrogenic component is unknown, Desirett should be discontinued in the event of a thrombosis. Discontinuation of Desirett should also be considered in case of long-term immobilisation due to surgery or illness. Women with a history of thrombo-embolic disorders should be made aware of the possibility of a recurrence.<br />Although progestogens may have an effect on peripheral insulin resistance and glucose tolerance, there is no evidence for a need to alter the therapeutic regimen in diabetics using progestogen-only pills. However, diabetic patients should be carefully observed during the first months of use.<br />If sustained hypertension develops during the use of Desirett, or if a significant increase in blood pressure does not adequately respond to antihypertensive therapy, the discontinuation of Desirett should be considered.</p><p>Treatment with Desirett leads to decreased estradiol serum levels, to a level corresponding with the early follicular phase. It is as yet unknown whether the decrease has any clinically relevant effect on bone mineral density.<br />The protection with traditional progestogen-only pills against ectopic pregnancies is not as good as with combined oral contraceptives, which has been associated with the frequent occurrence of ovulations during the use of progestogenonly pills. Despite the fact that Desirett consistently inhibits ovulation, ectopic pregnancy should be taken into account in the differential diagnosis if the woman gets amenorrhoea or abdominal pain.<br />Chloasma may occasionally occur, especially in women with a history of chloasma gravidarum. Women with a tendency to chloasma should avoid exposure to the sun or ultraviolet radiation whilst taking Desirett.<br />The following conditions have been reported both during pregnancy and during sex steroid use, but an association with the use of progestogens has not been established: jaundice and/or pruritus related to cholestasis; gallstone formation; porphyria; systemic lupus erythematosus; haemolytic uraemic syndrome; Sydenham&#39;s chorea; herpes gestations; otosclerosis-related hearing loss; (hereditary) angioedema.<br />Each tablet of this medicinal product contains 55 mg of lactose.<br />Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption not take this medicinal product.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Interactions between hormonal contraceptives and other medicinal products may lead to breakthrough bleeding and/or contraceptive failure. The following interactions have been reported in the literature (mainly with combined contraceptives but occasionally also with progestogen-only contraceptives).<br />Hepatic metabolism: Interactions can occur with medicinal products that induce microsomal enzymes, which can result in increased clearance of sex hormones (such as, hydantoins, (e.g. phenytoin), barbiturates (e.g. phenobarbital), primidone, carbamazepine, rifampicin, and possibly also for oxcarbazepine, topiramate, rifabutin, felbamate, ritonavir, nelfinavir, griseofulvin and products containing St. John&#39;s wort (Hypericum perforatum))<br />Maximal enzyme induction is not seen for 2-3 weeks, but may then be sustained for at least 4 weeks after cessation of drug therapy.<br />Women on treatment with any of these medicinal products should temporarily use a barrier method in addition to Desirett. With microsomal enzyme-inducing drugs, the barrier method should be used during the time of concomitant drug administration and for 28 days after discontinuation. For women on long-term treatment with hepatic enzyme inducers a non-hormonal method of contraception should be considered.<br />During the treatment with medical charcoal, the absorption of steroid in the tablet may be reduced and thereby the contraceptive efficacy. Under these circumstances the advice as given for missed pills in Section 4.2 is applicable.</p><p>Hormonal contraceptives may interfere with the metabolism of other drugs. Accordingly, plasma and tissue concentrations may either increase (e.g. cyclosporin) or decrease.<br />Note: The prescribing information of concomitant medications should be consulted to identify potential interactions.<br />Laboratory tests<br />Data obtained with COCs have been shown that contraceptive steroids may influence the results of certain laboratory tests, including biochemical parameters of liver, thyroid, adrenal and renal function, serum levels of (carrier) proteins, e.g. corticosteroid binding globulin and lipid/lipoprotein fractions, parameters of carbohydrate metabolism and parameters of coagulation and fibrinolysis. The changes generally remain within normal range. To what extent this also applies to progestogen-only contraceptives is not known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Desirett is not indicated during pregnancy. When pregnancy occurs during treatment with Desirett, further intake should be stopped.<br />Animal studies have shown that very high doses of progestagenic substances might cause masculinisation of female foetuses.<br />Extensive epidemiological studies have revealed neither an increased risk of birth defects in children born to women who used COCs before pregnancy, nor a teratogenic effect when COCs were taken inadvertently during early pregnancy. Pharmacovigilance data collected with various desogestrel-containing combined COCs also do not indicate an increased risk.<br />Lactation<br />Desirett does not influence the production or the quality (protein, lactose, or fat concentrations) of breast milk. However, small amounts of etonogestrel are excreted in the breast milk. As a result, 0.01 - 0.05 microgram etonogestrel per kg body weight per day might be ingested by the child (based on an estimated milk ingestion of 150 ml/kg/day).<br />Limited long-term follow up data are available on children, whose mothers started using Desirett during the 4th to 8th weeks post-partum. They were breast-fed for 7 months and followed up to 1.5 uears (n=32) or to 2.5 years (n=14) of age. Evaluation of growth and physical and psychomotor development did not indicate any differences compared with nursing infants, whose mother used a copper IUD. Based on the available data Desirett may be used during lactation. The development and growth of a nursing infant, whose mother uses Desirett, should however, be carefully observed.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Desirett has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported undesirable effect in the clinical trials is bleeding irregularity. Some kind of bleeding irregularity has been reported in up to 50% of women using Desirett. Since Desirett causes ovulation inhibition close to 100%, in contrast to other progestogen-only pills, irregular bleeding is more common than with other progestogen-only pills. In 20 - 30% of the women, bleeding may become more frequent, whereas in another 20% bleeding may become less frequent or totally absent. Vaginal bleeding may also be of longer duration. After a couple of months of treatment, bleedings tend to become less frequent. Information, counselling and a bleeding diary can improve the woman&rsquo;s acceptance of the bleeding pattern.<br />The most commonly reported other side effects in the clinical trials with Desirett (&gt;2.5%) were acne, mood changes, breast pain, nausea and weight increase. The side effects mentioned below have been judged by the investigators as having an established, probable or possible link to the treatment.<br />The adverse reactions are listed below classified by frequency according to the following criteria:<br />Very common: &ge;1/10<br />Common: &ge;1/100 to &lt;1/10<br />Uncommon: &ge;1/1,000 to &lt;1/100<br />Rare: &ge;1/10,000 to &lt;1/1,000<br />Very rare: &lt;1/10,000<br />Infections and infestations<br />Uncommon: vaginal infection.<br />Psychiatric disorders<br />Common: mood altered, libido decreased, depressed mood<br />Nervous system disorders<br />Common: headache<br />Eye disorders<br />Uncommon: contact lens intolerance<br />Gastrointestinal disorders<br />Common: nausea<br />Uncommon: vomiting<br />Skin and subcutaneous tissue disorders<br />Common: acne.<br />Uncommon: alopecia.<br />Rare: rash, urticaria, erythema nodosum.<br />Reproductive system and breast disorders<br />Common: breast pain, menstruation irregular, amenorrhoea.<br />Uncommon: dysmenorrhoea, ovarian cyst<br />General disorders and administration site conditions<br />Uncommon: fatigue</p><p>Investigations<br />Common: weight increased<br />Breast discharge may occur during use of Desirett. On rare occasions, ectopic pregnancies have been reported (see Section 4.4).<br />In women using (combined) oral contraceptives a number of (serious) undesirable effects have been reported. These include venous thromboembolic disorders, arterial thromboembolic disorders, hormone-dependent tumours (e.g. liver tumours, breast cancer) and chloasma some of which are discussed in more detail in Section 4.4.<br />To report any side effect(s):<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There have been no reports of serious adverse effects from overdose. Symptoms that may be caused by overdose are nausea, vomiting and, in young girls, slight vaginal bleeding. There are no antidotes and the treatment is symptomatic.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: hormonal contraceptives for systemic use,<br />ATC code: G03AC09.<br />Desirett is a progestogen-only pill, which contains the progestogen desogestrel. Like other progestogen-only pills, Desirett is best suited for use during breast feeding and for women who may not or do not want to use oestrogens. In contrast to traditional progestogen-only pills, the contraceptive effect of Desirett is achieved primarily by inhibition of ovulation. Other effects include increased viscosity of the cervical mucus.<br />When studied for 2 cycles, using a definition of ovulation as a progesterone level greater than 16 nmol/L for 5 consecutive days, the ovulation incidence was found to be 1% (1/103) with a 95% confidence interval of 0.02% -5.29% in the ITT group (user and method failures). Ovulation inhibition was achieved from the first cycle of use. In this study, when Desirett was discontinued after 2 cycles (56 continuous days) ovulation occurred on average after 17 days (range 7-30 days).<br />In a comparative efficacy trial (which allowed a maximum time of 3 hours for missed pills), the overall ITT Pearl&ndash;Index found for Desirett was 0.4 (95% confidence interval 0.09% - 1.20%), compared to 1.6 (95% confidence interval 0.42% - 3.96%) for 30 &mu;g levonorgestrel.</p><p>The Pearl-Index for Desirett is comparable to the one historically found for COCs in the general COC-using population. Treatment with Desirett leads to decreased estradiol levels, to a level corresponding to the early follicular phase. No clinically relevant effects on carbohydrate metabolism, lipid metabolism and haemostasis have been observed.<br />Paediatric population<br />No clinical data on efficacy and safety are available in adolescents below 18 years.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />After oral dosing of Desirett, desogestrel (DSG) is rapidly absorbed and converted into etonogestrel (ENG). Under steady-state conditions, peak serum levels are reached 1.8 hours after tablet-intake and the absolute bioavailability of ENG is approximately 70%.<br />Distribution<br />ENG is 95.5-99% bound to serum proteins, predominantly to albumin and to a lesser extent to SHBG.<br />Metabolism<br />DSG is metabolised via hydroxylation and dehydrogenation to the active metabolite ENG. ENG is metabolised via sulphate and glucuronide conjugation.<br />Elimination<br />ENG is eliminated with a mean half-life of approximately 30 hours, with no difference between single and multiple dosing. Steady-state levels in plasma are reached after 4-5 days. The serum clearance after IV administration of ENG is approximately 10 l per hour. Excretion of ENG and its metabolites either as free steroid or as conjugates, is with urine and faeces (ratio 1.5:1). In lactating women, ENG is excreted in breast milk with a milk/serum ratio of 0.37-0.55.<br />Based on these data and an estimated milk intake of 150 ml/kg/day, 0.01 - 0.05 microgram etonogestrel may be ingested by the infant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Toxicological studies did not reveal any effects other than those, that can be explained from the hormonal properties of desogestrel.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet core:<br />Lactose monohydrate<br />Maize starch<br />Povidone K30<br />d-&alpha;-Tocopherol<br />Soybean oil<br />Silica, colloidal anhydrous<br />Silica, colloidal hydrated<br />Stearic acid<br />Coating:<br />Hypromellose 2910<br />Polyethylene Glycol</p><p>Titanium Dioxide (E 171)</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30oC</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blisters of aluminium push-through foil and PVC/PVDC film.<br />Pack sizes:<br />1 x 28 film-coated tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The active substance etonogestrel shows an environmental risk to fish<br />No special requirements.<br />Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Exeltis Germany GMBH
Adalperostr. 84
85737 Ismaning,
Germany
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                September 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>